Pharmaceutical companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 44 pharmaceutical companies in the United States ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- TG Therapeutics19.0%
- Median
- 7.16%
- Combined market value
- ZAR 65.27T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | ZAR 171.3B | ZAR 1,133.53 | 1.88% down | 103% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | ZAR 141.5B | ZAR 2,040.64 | 1.88% down | 15% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | ZAR 83.5B | ZAR 1,482.08 | 1.01% up | 105% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | ZAR 141.4B | ZAR 2,166.78 | 2.47% down | 45% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | ZAR 151.8B | ZAR 5,431.80 | 1.87% up | 83% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | ZAR 125.2B | ZAR 899.07 | 0.27% up | 21% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | ZAR 79.2B | ZAR 475.57 | 0.62% down | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | ZAR 100.3B | ZAR 5,013.19 | 3.94% down | 44% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | ZAR 162B | ZAR 1,705.71 | 3.77% down | 302% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | ZAR 78.7B | ZAR 719.29 | 0.48% down | 82% up | ||
| 11 | BridgeBio PharmaBBIO · Health Care | 10.7% | ZAR 266.1B | ZAR 1,365.90 | 0.22% up | 15% up | ||
| 12 | ErascaERAS · Health Care | 10.6% | ZAR 87.2B | ZAR 248.44 | 3.34% up | 387% up | ||
| 13 | Cogent BiosciencesCOGT · Health Care | 10.0% | ZAR 84.3B | ZAR 484.65 | 0.25% down | 25% down | ||
| 14 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | ZAR 108.9B | ZAR 1,668.67 | 3.27% up | 35% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | 9.96% | ZAR 81B | ZAR 843.86 | 3.86% down | 39% up | ||
| 16 | Oruka TherapeuticsORKA · Health Care | 9.53% | ZAR 115.6B | ZAR 1,704.66 | 1.91% up | 233% up | ||
| 17 | PTC TherapeuticsPTCT · Health Care | 9.31% | ZAR 85.1B | ZAR 1,019.01 | 3.16% down | 26% down | ||
| 18 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | ZAR 161B | ZAR 6,931.52 | 0.34% down | 28% down | ||
| 19 | Corcept TherapeuticsCORT · Health Care | 8.34% | ZAR 124.2B | ZAR 1,135.28 | 4.15% down | 16% down | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | ZAR 107.8B | ZAR 762.62 | 1.25% up | 8% up | ||
| 21 | VeradermicsMANE · Health Care | 8.03% | ZAR 91.7B | ZAR 2,173.24 | 0.38% down | 230% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | ZAR 207.9B | ZAR 1,073.08 | 0.02% down | 12% up | ||
| 23 | Definium TherapeuticsDFTX · Health Care | 7.02% | ZAR 70.5B | ZAR 515.05 | 1.24% up | 176% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | 6.59% | ZAR 229.6B | ZAR 459.32 | 1.54% down | 18% up | ||
| 25 | InsmedINSM · Health Care | 6.42% | ZAR 553.7B | ZAR 2,523.89 | 20.58% up | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | 6.20% | ZAR 124.7B | ZAR 2,370.49 | 1.25% up | 9% down | ||
| 27 | Legend BiotechLEGN · Health Care | 6.13% | ZAR 54.6B | ZAR 281.29 | 0.92% down | 43% down | ||
| 28 | Summit TherapeuticsSMMT · Health Care | 5.28% | ZAR 147.7B | ZAR 184.67 | 0.67% up | 35% down | ||
| 29 | United TherapeuticsUTHR · Health Care | 4.31% | ZAR 416B | ZAR 9,768.15 | 3.16% down | 18% up | ||
| 30 | ZoetisZTS · Health Care | 4.12% | ZAR 573.5B | ZAR 1,411.50 | 5.59% down | 34% down | ||
| 31 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | ZAR 345.9B | ZAR 2,582.59 | 1.06% down | 66% down | ||
| 32 | Belite BioBLTE · Health Care | 3.40% | ZAR 107.2B | ZAR 2,638.50 | 3.33% down | 25% up | ||
| 33 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | ZAR 130.2B | ZAR 373.71 | 2.24% down | 79% up | ||
| 34 | ViatrisVTRS · Health Care | 3.07% | ZAR 398.2B | ZAR 347.33 | 1.97% down | 90% up | ||
| 35 | PfizerPFE · Health Care | 2.36% | ZAR 2.74T | ZAR 481.16 | 1.85% down | 10% up | ||
| 36 | Bristol-Myers SquibbBMY · Health Care | 2.29% | ZAR 2.08T | ZAR 1,019.27 | 2.05% down | 26% up | ||
| 37 | Royalty PharmaRPRX · Health Care | 2.27% | ZAR 680.3B | ZAR 1,183.15 | 1.38% down | 74% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | ZAR 1.67T | ZAR 16,131.86 | 2.35% down | 22% up | ||
| 39 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | ZAR 2.31T | ZAR 9,096.55 | 2.94% down | 22% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 1.10% | ZAR 3.14T | ZAR 1,814.73 | 0.58% down | 19% down | ||
| 41 | Merck & CoMRK · Health Care | 1.08% | ZAR 5.72T | ZAR 2,320.35 | 3.61% down | 36% up | ||
| 42 | AbbVieABBV · Health Care | 0.89% | ZAR 8.76T | ZAR 4,953.78 | 0.86% down | 20% up | ||
| 43 | Eli LillyLLY · Health Care | 0.81% | ZAR 21.03T | ZAR 23,605.69 | 2.29% down | 28% up | ||
| 44 | Johnson & JohnsonJNJ · Health Care | 0.71% | ZAR 11.24T | ZAR 4,667.26 | 2.04% down | 31% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4712 ZAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 44 pharmaceutical companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by short interest.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of ZAR 65.27T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.